World's Best Scientists 2026 revealed!
David Klatzmann

David Klatzmann

D-Index & Metrics

Immunology

D-Index
99
Citations
36800
World Ranking
748
National Ranking
23

Medicine

D-Index
99
Citations
36925
World Ranking
8582
National Ranking
262

David Klatzmann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David Klatzmann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 517 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David Klatzmann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David Klatzmann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David Klatzmann is affiliated with Sorbonne University in France and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research spans several subfields, including Immunology, Rheumatology, Oncology, Molecular Biology, and Genetics.

The scientist's main topics of work include:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Systemic Lupus Erythematosus Research
  • Atherosclerosis and Cardiovascular Diseases
  • Immunotherapy and Immune Responses
  • Tryptophan and brain disorders
  • IL-33, ST2, and ILC Pathways

Their recent scholarly output includes several papers of note:

  • "Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage," 2020, published in Science
  • "A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers," 2023, published in Science
  • "Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis," 2023, published in Cancer Discovery
  • "Polyclonal expansion of TCR Vβ 21.3 + CD4 + and CD8 + T cells is a hallmark of multisystem inflammatory syndrome in children," 2021, published in Science Immunology
  • "Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities," 2020, published in Autoimmunity Reviews

David Klatzmann frequently collaborates with other researchers, including:

  • Michèlle Rosenzwajg
  • Encarnita Mariotti-Ferrandiz
  • Nicolas Tchitchek
  • P. Cacoub
  • David Saadoun

They have published numerous works in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of the Rheumatic Diseases
  • La Revue de Médecine Interne
  • Journal of Autoimmunity
  • Osteoarthritis and Cartilage

David Klatzmann's research reflects a multidisciplinary approach with a strong emphasis on immunological mechanisms and their implications across various diseases. Their work touches on fundamental immune cell interactions as well as clinical complications related to immune checkpoint inhibitors and systemic diseases.

Best Publications

  • T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

    David Klatzmann;Eric Champagne;Sophie Chamaret;Jacqueline Gruest

  • Natural regulatory T cells control the development of atherosclerosis in mice.

    Hafid Ait-Oufella;Benoît L Salomon;Stéphane Potteaux;Anna-Karin L Robertson

  • Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

    D Klatzmann;F Barré-Sinoussi;M T Nugeyre;C Danquet

  • CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

    José L. Cohen;Aurélie Trenado;Douglas Vasey;David Klatzmann

  • Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

    David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  • Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

    Pierre Sonigo;Marc Alizon;Katherine Staskus;David Klatzmann

  • The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

    David Klatzmann;Abul K. Abbas

  • Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State

    Sylvain Fisson;Guillaume Darrasse-Jèze;Elena Litvinova;Franck Septier

  • Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

    Aurélie Trenado;Frédéric Charlotte;Sylvain Fisson;Micael Yagello

  • Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.

    Manuel Caruso;Yves Panis;Singh Gagandeep;Didier Houssin

  • A novel dendritic cell subset involved in tumor immunosurveillance.

    Julien Taieb;Nathalie Chaput;Cédric Ménard;Lionel Apetoh

  • Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice

    Muriel Sudres;Françoise Norol;Aurélie Trenado;Sylvie Grégoire

  • IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

    Yenkel Grinberg-Bleyer;Audrey Baeyens;Sylvaine You;Rima Elhage

  • Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice

    Bart N. Lambrecht;Benoı̂t Salomon;David Klatzmann;Romain A. Pauwels

  • Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

    L. Montagnier;J. Gruest;S. Chamaret;C. Dauguet

  • Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    Agnès Hartemann;Gilbert Bensimon;Christine A Payan;Sophie Jacqueminet

  • Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.

    R. A. Dewey;G. Morrissey;C. M. Cowsill;D. Stone

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Recurrent Glioblastoma

    David Klatzmann;Charles A. Valéry;Gilbert Bensimon;Beatrice Marro

  • Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.

    Aurélie Fluckiger;Aurélie Fluckiger;Romain Daillère;Romain Daillère;Mohamed Sassi;Barbara Susanne Sixt

  • Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

    nathalie chaput;Samy Louafi;armelle Bardier;frederic charlotte

Frequent Co-Authors

Michelle Rosenzwajg
Michelle Rosenzwajg Sorbonne University
Benoît L. Salomon
Benoît L. Salomon Sorbonne University
Patrice Cacoub
Patrice Cacoub Sorbonne University
David Saadoun
David Saadoun Université Paris Cité
Luc Montagnier
Luc Montagnier Institut Pasteur
Olivier Benveniste
Olivier Benveniste Sorbonne University
Olivier Boyer
Olivier Boyer University of Rouen
Lucile Musset
Lucile Musset Sorbonne University
Frédéric Charlotte
Frédéric Charlotte Université Paris Cité
Maria G. Castro
Maria G. Castro University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, pursuing a nursing pathway can be a valuable option. Many professionals transition to advanced practice roles through accredited acnp programs, which specialize in acute care nurse practitioner training. These programs build crucial skills needed for managing complex patient cases.

Accelerated educational routes are particularly popular for students seeking to fast-track their careers. High-quality accelerated nurse practitioner program options allow learners to complete rigorous training in a condensed timeframe, providing flexibility for working professionals.

For individuals without a nursing background interested in entering the field swiftly, 12-month accelerated nursing programs online for non nurses offer an accessible gateway. These programs offer comprehensive coursework designed to prepare new nurses efficiently.

Additionally, some may consider easing their entry with programs rated as the easiest accelerated nursing programs. These programs typically have more flexible admissions criteria and structured pathways to achieve a Bachelor of Science in Nursing with speed and effectiveness.

Best Scientists Citing David Klatzmann

Trending Scientists

Recently Published Articles